The small molecule C19 inhibits the viability and proliferation of colorectal cancer cells in vitro and in vivo, through decreased activation of KRAS and, therefore, inhibition of phosphorylation of downstream kinases such as AKT and ERK [77,78,79]. Here, KRAS is linked to colorectal cancer.